Drug information | |
Active Ingredient (Generic Name) | Pirfenidone |
Indication | Idiopathic pulmonary fibrosis |
Manufacturer | Cipla Ltd |
Packaging | 15 capsules in 1 strip |
Strength | 200mg |
Delivery Time | 18 To 20 days |
Pirfenex 200 Mg (Pirfenidone)
Pirfenex 200 Mg (Pirfenidone)
|
Variation | Price | Price / Unit | Quantity | Add To Cart |
---|---|---|---|---|
60 Tablet/s | $96.00 | $1.6/ Piece | ||
120 Tablet/s | $180.00 | $1.5/ Piece | ||
210 Tablet/s | $294.00 | $1.4/ Piece | ||
300 Tablet/s | $360.00 | $1.2/ Piece |
Product details
Select Your Quantity |
60 Tablet/s ,120 Tablet/s ,210 Tablet/s ,300 Tablet/s |
---|
Description
Customer Reviews
Rated 0 out of 5
0 reviews
Rated 5 out of 5
0
Rated 4 out of 5
0
Rated 3 out of 5
0
Rated 2 out of 5
0
Rated 1 out of 5
0
Be the first to review “Pirfenex 200 Mg (Pirfenidone)” Cancel reply
Related Products
$87.00 – $700.00
Select options
This product has multiple variants. The options may be chosen on the product page
$87.00 – $700.00
Select options
This product has multiple variants. The options may be chosen on the product page
$60.00 – $390.00
Select options
This product has multiple variants. The options may be chosen on the product page
$96.00 – $800.00
Select options
This product has multiple variants. The options may be chosen on the product page
$96.00 – $240.00
Select options
This product has multiple variants. The options may be chosen on the product page
$66.00 – $240.00
Select options
This product has multiple variants. The options may be chosen on the product page
$84.00 – $210.00
Select options
This product has multiple variants. The options may be chosen on the product page
$84.00 – $330.00
Select options
This product has multiple variants. The options may be chosen on the product page
$72.00 – $270.00
Select options
This product has multiple variants. The options may be chosen on the product page
$80.00 – $600.00
Select options
This product has multiple variants. The options may be chosen on the product page
Reviews
Clear filtersThere are no reviews yet.